{
    "organizations": [],
    "uuid": "51087203dc20e96f9b29d0cbc7be1af61226c810",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/07/the-associated-press-conatus-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Conatus reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $4.4 million in its fourth quarter.\nThe San Diego-based company said it had a loss of 15 cents per share.\nThe results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.\nThe biotechnology company posted revenue of $8.8 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $9.6 million.\nFor the year, the company reported that its loss narrowed to $17.4 million, or 61 cents per share. Revenue was reported as $35.4 million.\nConatus shares have risen 49 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $6.88, a climb of 59 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at https://www.zacks.com/ap/CNAT",
    "published": "2018-03-07T23:35:00.000+02:00",
    "crawled": "2018-03-08T00:11:29.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "conatus",
        "pharmaceutical",
        "cnat",
        "wednesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "per",
        "share",
        "result",
        "exceeded",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biotechnology",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "fell",
        "short",
        "street",
        "forecast",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "cent",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "conatus",
        "share",
        "risen",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "wednesday",
        "share",
        "hit",
        "climb",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "cnat",
        "http"
    ]
}